All News

A prevailing operational relationship with his pharmacy department was a major factor in winning a prestigious safety and quality award.

Doribax (doripenem for injection), a broad spectrum antibiotic, was recently approved by the FDA for the treatment of complicated intra-abdominal and complicated urinary tract infections.

Hospitals concerned about their infection rates may want to consider the use of a new pain relief device that potentially offers a two-pronged benefit – the reduction of pain and surgical site infections.

Hospital reduces medical errors with automatic drug dispensing/distribution system.

Gift cards promote polypharmacy

Medication reconciliation is important to patient safety and should be overseen by hospital pharmacists, but relatively few pharmacists have time to counsel patients.

Manufacturers are launching new over-the-counter medicines that are innovative.

Two Food and Drug Administration advisory committees voted 13 to 9 to recommend that cough and cold over-the-counter medications not be used for children who are more than two and less than six years old.

Drug-buying decision tools work, they save consumers money and we now have the statistics to prove it, according to a founder of one of the most prominent of those Web-based aids.

NCPA and NACDS have filed a preliminary injunction against CMS to stop the implementation of its average manufacturer price rule.

A New Jersey pharmacist was arrested for illegal diversion for selling stolen sample medications.

At an FDA public meeting to consider whether a behind-the-counter class of drugs should be set up, the agency heard from both supporters and detractors.

Roche obtains FDA approval for Mircera for dialysis patients, but a patent dispute with Amgen could tie up its marketing in the United States.

New safety information added to rosiglitazone label

Medco study reveals that many seniors did not adequately factor in rising healthcare costs when saving for retirement

NACDS announces Mary Ann Wagner's retirement

A coalition of doctors and scientists has filed a petition with FDA requesting that drugs be tested among humans, rather than animals, where feasible.

New technology designed to boost 340B participation

CMS has proposed a new rule for the Medicare Part D, which would adopt a new e-prescribing standard.

Rite Aid pharmacies help seniors during Medicare Part D enrollment.

Medco announces its plans to build a 318,000-sq. ft. mail-order pharmacy in Indiana.

Quality of care improving in nation's hospitals.

3M launches new inhaler dose counter.

Miami healthcare company owners in prison for Medicare fraud.

Genzyme has to provide FDA with more data on Synvisc-One before the pain-relieving treatment for osteoarthritis can be approved.

FDA adds new warnings to erythropoiesis-stimulating agents' labels.

New indication for rosuvastatin (Crestor) approved.

New delivery device approved for somatropin (Saizen).